Skip to main content
Top
Published in: Clinical Rheumatology 4/2021

01-04-2021 | Rheumatoid Arthritis | Original Article

Prevalence of rheumatoid arthritis in Edmonton and Northern Alberta

Authors: Jason Soo, David Eldeiry, Steven Katz

Published in: Clinical Rheumatology | Issue 4/2021

Login to get access

Abstract

Objective

The purpose of this study was to compare and contrast the prevalence of rheumatoid arthritis in Northern Alberta estimated by health administrative data and data from a rheumatologist-based prescription database.

Methods

The study was performed using administrative health data from the province of Alberta through the local health authority. The cases and population identified in the database were reported from the year 2016. Rheumatology prescribing data was accessed through the Physician Learning Program and based on Alberta health billing data of actively practicing rheumatologists between the years 2012 and 2016. Ethics was provided by the Conjoint Health Research Ethics Boards at the University of Calgary (REB 13-0459).

Results

The total population of the area examined was determined to be 2,086,181. The administrative health database identified 42,354 cases of RA based on their case definition with a prevalence of 2.08%. Based on rheumatologist diagnosis and prescribing data, the number of cases identified was 11,273 cases of RA with a prevalence of 0.542%. The average percentage of identified RA patients being seen by a rheumatologist was determined to be 26.7% with the range of 19.8 to 39.9%.

Conclusion

In conclusion, this study compares and contrasts the prevalence of rheumatoid arthritis reported by administrative data versus identification by specialists. Our study again illustrates that accuracy of case definitions when studying chronic conditions such as rheumatoid arthritis is paramount. The results also suggest a lack of access to rheumatologist services in Northern Alberta and reiterate the need for ongoing recruitment of new rheumatologists as has been highlighted previously.
Key Points
• The main contribution of this paper is to compare and contrast the prevalence of rheumatoid arthritis as reported by administrative data versus identification by specialists.
• Our study also shows the distribution of rheumatoid arthritis in a large geographical area and illustrates a lack of access to subspecialty care in certain regions.
Literature
1.
go back to reference Widdifield J, Paterson JM, Bernatsky S et al (2014) The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheum 66:786–793CrossRef Widdifield J, Paterson JM, Bernatsky S et al (2014) The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheum 66:786–793CrossRef
2.
go back to reference Barnabe C, Jones CA, Bernatsky S et al (2017) Inflammatory arthritis prevalence and health services use in the First Nations and non–First Nations Populations of Alberta, Canada. Arthritis Care Res 69:467–474CrossRef Barnabe C, Jones CA, Bernatsky S et al (2017) Inflammatory arthritis prevalence and health services use in the First Nations and non–First Nations Populations of Alberta, Canada. Arthritis Care Res 69:467–474CrossRef
3.
go back to reference Bernatsky S, Dekis A, Hudson M et al (2014) Rheumatoid arthritis prevalence in Quebec. BMC Res Notes 7:937CrossRef Bernatsky S, Dekis A, Hudson M et al (2014) Rheumatoid arthritis prevalence in Quebec. BMC Res Notes 7:937CrossRef
4.
go back to reference Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 53:241–248CrossRef Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 53:241–248CrossRef
5.
go back to reference Hanly JG, Thompson K, Skedgel C (2015) The use of administrative health care databases to identify patients with rheumatoid arthritis. Open Access Rheumatol 7:69–75CrossRef Hanly JG, Thompson K, Skedgel C (2015) The use of administrative health care databases to identify patients with rheumatoid arthritis. Open Access Rheumatol 7:69–75CrossRef
7.
go back to reference Barber CE, Patel JN, Woodhouse L et al (2015) Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 17:322CrossRef Barber CE, Patel JN, Woodhouse L et al (2015) Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 17:322CrossRef
Metadata
Title
Prevalence of rheumatoid arthritis in Edmonton and Northern Alberta
Authors
Jason Soo
David Eldeiry
Steven Katz
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05352-5

Other articles of this Issue 4/2021

Clinical Rheumatology 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.